Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qixun Chen

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Biomolecules & Biomedicine|July 26, 2022
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|July 22, 2024
Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapyQiang Zhao, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|November 13, 2023
A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Journal of Cardiothoracic Surgery|September 15, 2021
Peripheral pure ground-glass opacity: segmentectomy versus wedge resectionTaobo Luo, Qixun Chen, Jian Zeng, et al.
Annals of Surgical Oncology|October 14, 2023
ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell CarcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Oncology|April 14, 2023
Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancerXiao Wu, Youhua Jiang, Qixun Chen, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2019
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective studyLei Gong, Weimin Mao, Qixun Chen, et al.
Frontiers in Immunology|August 22, 2025
Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyQiang Zhao, Liang Wang, Xun Yang, et al.
Journal of Thoracic Disease|November 17, 2022
Dorsal incision shows more efficacy and safety to traditional incision in single-portal video-assisted thoracoscopic surgery segmentectomy of LS9+10: a non-randomized prospective clinical trialTaobo Luo, Qixun Chen, Jian Zeng, et al.
International Immunopharmacology|June 12, 2023
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Biomolecules & Biomedicine|July 26, 2022
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world studyJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|July 22, 2024
Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapyQiang Zhao, Liang Wang, Xun Yang, et al.
Frontiers in Immunology|November 13, 2023
A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Journal of Cardiothoracic Surgery|September 15, 2021
Peripheral pure ground-glass opacity: segmentectomy versus wedge resectionTaobo Luo, Qixun Chen, Jian Zeng, et al.
Annals of Surgical Oncology|October 14, 2023
ASO Author Reflections: A Novel, Sensitive, and Effective Index in Predicting Therapeutic Response of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell CarcinomaJifeng Feng, Liang Wang, Xun Yang, et al.
Frontiers in Oncology|April 14, 2023
Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancerXiao Wu, Youhua Jiang, Qixun Chen, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2019
Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective studyLei Gong, Weimin Mao, Qixun Chen, et al.
Frontiers in Immunology|August 22, 2025
Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapyQiang Zhao, Liang Wang, Xun Yang, et al.
Journal of Thoracic Disease|November 17, 2022
Dorsal incision shows more efficacy and safety to traditional incision in single-portal video-assisted thoracoscopic surgery segmentectomy of LS9+10: a non-randomized prospective clinical trialTaobo Luo, Qixun Chen, Jian Zeng, et al.
International Immunopharmacology|June 12, 2023
Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapyJifeng Feng, Liang Wang, Xun Yang, et al.
Pageof 9